Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 31 for lymphoma OR "lymphoma," "T-cell"
  1. ... white blood cells that normally fights infection); cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune ...
  2. ... white blood cells that normally fights infection); cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune ...
  3. ... tumor in adults and children; to treat cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune ...
  4. Vorinostat is used to treat cutaneous T-cell lymphoma (CTCL, a type of cancer) in people whose disease has not improved, has gotten worse, or has come back after taking other ...
  5. Bexarotene is used to treat cutaneous T-cell lymphoma (CTCL, a type of lymphoma [cancer] that attacks the skin) in people whose disease could not be treated successfully with at least ...
  6. Topical bexarotene is used to treat cutaneous T-cell lymphoma (CTCL, a type of lymphoma [cancer] that attacks the skin that could not be treated with other medications. Bexarotene is in a class ...
  7. Pralatrexate injection is used to treat peripheral T-cell lymphoma (PTCL; a form of cancer that begins in a certain type of cells in the immune system) that has not improved or that ...
  8. Denileukin diftitox is used to treat cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune system that first appear as skin rashes) in people whose disease has not improved, has ...
  9. Romidepsin injection is used to treat cutaneous T-cell lymphoma (CTCL; a group of cancers of the immune system that first appear as skin rashes) in people who have already been treated with ...
  10. ... to treat early stage mycosis fungoides-type cutaneous T-cell lymphoma (CTCL; a cancer of the immune system that ...
previous · 1 · 2 · 3 · 4 · next